Background: In recent years different IRT/PAP protocols have been evaluated, but the individual performance remains unclear. To optimize the IRT/PAP strategy we compared protocols from three regional CF newborn screening centers (Heidelberg, Dresden, and Prague).
Methods: We evaluated the effect of elevating the IRT-cut-off from 50 to 65 μg/l (~97.5th to ~99.0th percentile), the need of a failsafe protocol (FS, IRT ≥ 99.9th percentile) and the relative performance using either two IRT-dependent PAP-cut-offs or one PAP-cut-off.
Findings: Elevation of the IRT cut-off to 65 μg/l (~99.0th percentile) increased the PPV significantly (Dresden: 0.065 vs. 0.080, p < 0.0001, Prague: 0.052 vs. 0.074, p < 0.0001) without reducing sensitivity. All three IRT/PAP protocols showed a trend towards a higher sensitivity with FS than without and when using one PAP-cut-off instead of two IRT-dependent PAP-cut-offs.
Conclusions: For best performance we suggest an IRT/PAP protocol with an IRT-cut-off close to the 99.0th percentile, FS, and a single PAP-cut-off.
Keywords: Biochemical screening; CF; CFNBS; Cystic fibrosis; DBS; FS; IRT; Immunoreactive trypsinogen; MI; NBS; Newborn screening; PAP; PI; PS; Pancreatitis associated protein; cystic fibrosis; cystic fibrosis newborn screening; dried blot spot; failsafe strategy; immunoreactive trypsinogen; meconium ileus; newborn screening; pancreatic insufficient; pancreatic sufficient; pancreatitis associated protein.
© 2013.